Children with pediatric-onset multiple sclerosis (POMS) have shorter telomeres, suggesting MS may accelerate biological aging.
Based on early Phase I/II data, investigators at Cincinnati Children's are enrolling more patients with a telomere biology ...
Telomir Pharmaceuticals (NASDAQ: TELO) announced new preclinical findings demonstrating that its proprietary compound, Telomir-1, fully reverses calc ...
A new proteomic aging clock may predict biological age, mortality risk, and the likelihood of age-related diseases, though ...
Early results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...
The Food and Drug Administration (FDA) has granted Orphan Drug designation to EXG-34217 for the treatment of telomere biology disorders.
Data published in NEJM Evidence detail the first clinical test of ZSCAN4 for telomere elongation.Treatment with EXG-34217 resulted in in vivo ...
Researchers from Osaka University, Japan claim to have found a cellular 'master switch' which can reverse the process of ...
Saccharina japonica, one of the most widely cultivated seaweeds globally, is particularly prominent along China's coastline, ...
Telomir Pharmaceuticals (NASDAQ: TELO) announced a breakthrough with its Telomir-1 platform, successfully stabilizing both Silver(I) (Ag+) and highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results